Advertisement

Host–Pathogen Interactions in Streptococcal Immune Sequelae

  • D. Patric Nitsche-SchmitzEmail author
  • Gursharan S. Chhatwal
Chapter
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 368)

Abstract

Otherwise uncomplicated infections with Streptococcus pyogenes can cause two insidious immune sequelae known as post-streptococcal glomerulonephritis (PSGN) and acute rheumatic fever (ARF). These diseases follow with a latency of a few weeks or months after primary infection and are responsible for high mortality and morbidity. PSGN has also been linked to infections with group C streptococci of the species S. equi ssp. zooepidemicus (SESZ). Moreover, there are some indications that infection with group C and G streptococci (GCGS) of the subspecies Streptococcus dysgalactiae ssp. equisimilis (SDSE) leads to ARF. Despite decades of research, the picture of the molecular pathogenesis of streptococcal immune sequelae resembles a jigsaw puzzle. Herein we try to put some of the puzzle bits together that have been collected till date.

Keywords

Hyaluronic Acid Rheumatic Heart Disease Complement Factor Molecular Mimicry Acute Rheumatic Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Adderson EE, Shikhman AR, Ward KE, Cunningham MW (1998) Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol 161(4):2020–2031PubMedGoogle Scholar
  2. Åkesson P, Sjöholm AG, Björck L (1996) Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271(2):1081–1088PubMedCrossRefGoogle Scholar
  3. Andres GA, Accinni L, Hsu KC, Zabriskie JB, Seegal BC (1966) Electron microscopic studies of human glomerulonephritis with ferritin-conjugated antibody. Localization of antigen-antibody complexes in glomerular structures of patients with acute glomerulonephritis. J Exp Med 123(2):399–412PubMedCrossRefGoogle Scholar
  4. Anonymous (1979) Klebsiella and ankylosing spondylitis--molecular mimicry? Lancet 1(8124):1012–1013Google Scholar
  5. Balter S, Benin A, Pinto SW, Teixeira LM, Alvim GG, Luna E, Jackson D, LaClaire L, Elliott J, Facklam R, Schuchat A (2000) Epidemic nephritis in Nova Serrana Brazil. Lancet 355(9217):1776–1780PubMedCrossRefGoogle Scholar
  6. Barnham M, Thornton TJ, Lange K (1983) Nephritis caused by Streptococcus zooepidemicus (lancefield group C). Lancet 1(8331):945–948PubMedCrossRefGoogle Scholar
  7. Barroso V, Rohde M, Davies MR, Gillen CM, Nitsche-Schmitz DP, Dinkla K, Chhatwal GS (2009) Identification of active variants of PARF in human pathogenic group C and group G streptococci leads to an amended description of its consensus motif. Int J Med Microbiol 299(8):547–553PubMedCrossRefGoogle Scholar
  8. Batsford SR, Mezzano S, Mihatsch M, Schiltz E, Rodriguez-Iturbe B (2005) Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 68(3):1120–1129PubMedCrossRefGoogle Scholar
  9. Bauer MJ, Georgousakis MM, Vu T, Henningham A, Hofmann A, Rettel M, Hafner LM, Sriprakash KS, McMillan DJ (2012) Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein. Vaccine 30(12):2197–2205PubMedCrossRefGoogle Scholar
  10. Beres SB, Sesso R, Pinto SW, Hoe NP, Porcella SF, Deleo FR, Musser JM (2008) Genome sequence of a lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One 3(8):e3026PubMedCrossRefGoogle Scholar
  11. Berge A, Björck L (1995) Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270(17):9862–9867PubMedCrossRefGoogle Scholar
  12. Blank M, Barzilai O, Shoenfeld Y (2007) Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 32(1):111–118PubMedCrossRefGoogle Scholar
  13. Bober M, Mörgelin M, Olin AI, von Pawel-Rammingen U, Collin M (2011) The membrane bound LRR lipoprotein Slr, and the cell wall-anchored M1 protein from Streptococcus pyogenes both interact with type I collagen. PLoS One 6(5):e20345PubMedCrossRefGoogle Scholar
  14. Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56–59PubMedCrossRefGoogle Scholar
  15. Bramhachari PV, Kaul SY, McMillan DJ, Shaila MS, Karmarkar MG, Sriprakash KS (2010) Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. J Med Microbiol 59(Pt 2):220–223PubMedCrossRefGoogle Scholar
  16. Bronze MS, Beachey EH, Dale JB (1988) Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein. J Exp Med 167(6):1849–1859PubMedCrossRefGoogle Scholar
  17. Broyles LN, Van Beneden C, Beall B, Facklam R, Shewmaker PL, Malpiedi P, Daily P, Reingold A, Farley MM (2009) Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 48(6):706–712PubMedCrossRefGoogle Scholar
  18. Carapetis JR, McDonald M, Wilson NJ (2005a) Acute rheumatic fever. Lancet 366(9480):155–168PubMedCrossRefGoogle Scholar
  19. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005b) The global burden of group A streptococcal diseases. Lancet Infect Dis 5(11):685–694PubMedCrossRefGoogle Scholar
  20. Chan AL, Louie S, Leslie KO, Juarez MM, Albertson TE (2011) Cutting edge issues in Goodpasture’s disease. Clin Rev Allergy Immunol 41(2):151–162PubMedCrossRefGoogle Scholar
  21. Chhatwal GS, Graham RM (2008) Streptococcal diseases. In: Encyclopedia of public health 2008, vol 6, Academic Press, San Diego, pp 231–241Google Scholar
  22. Chong BF, Blank LM, McLaughlin R, Nielsen LK (2005) Microbial hyaluronic acid production. Appl Microbiol Biotechnol 66(4):341–351PubMedCrossRefGoogle Scholar
  23. Cochrane CG (1971) Mechanisms involved in the deposition of immune complexes in tissues. J Exp Med 134(3):75–89PubMedGoogle Scholar
  24. Cu GA, Mezzano S, Bannan JD, Zabriskie JB (1998) Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int 54(3):819–826PubMedCrossRefGoogle Scholar
  25. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470–511PubMedCrossRefGoogle Scholar
  26. Cunningham MW (2003) Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci 8:533–543CrossRefGoogle Scholar
  27. Cunningham MW (2012) Streptococcus and rheumatic fever. Curr Opin Rheumatol 24(4):408–416PubMedCrossRefGoogle Scholar
  28. Cunningham MW, Russell SM (1983) Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect Immun 42(2):531–538PubMedGoogle Scholar
  29. Cunningham MW, Krisher K, Graves DC (1984) Murine monoclonal antibodies reactive with human heart and group A streptococcal membrane antigens. Infect Immun 46(1):34–41PubMedGoogle Scholar
  30. Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB (1989) Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 143(8):2677–2683PubMedGoogle Scholar
  31. Dale JB, Beachey EH (1985a) Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 162(2):583–591PubMedCrossRefGoogle Scholar
  32. Dale JB, Beachey EH (1985b) Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med 161(1):113–122PubMedCrossRefGoogle Scholar
  33. Dale JB, Beachey EH (1986) Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med 164(5):1785–1790PubMedCrossRefGoogle Scholar
  34. Dale JB, Penfound TA, Chiang EY, Walton WJ (2011) New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 29(46):8175–8178PubMedCrossRefGoogle Scholar
  35. Daly C, Mitchell D, Grossberg D, Highfield J, Stewart D (1997) Bacteraemia caused by periodontal probing. Aust Dent J 42(2):77–80PubMedCrossRefGoogle Scholar
  36. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalen C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45(4):450–458PubMedCrossRefGoogle Scholar
  37. Dedeoglu IO, Springate JE, Waz WR, Stapleton FB, Feld LG (1996) Prolonged hypocomplementemia in post streptococcal acute glomerulonephritis. Clin Nephrol 46(5):302–305PubMedGoogle Scholar
  38. Dick GF, Dick GH (1983) Landmark article Jan 26, 1924: the etiology of scarlet fever. By George F. Dick and Gladys Henry Dick. JAMA 250(22):3096PubMedCrossRefGoogle Scholar
  39. Dinkla K, Rohde M, Jansen WT, Kaplan EL, Chhatwal GS, Talay SR (2003) Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest 111(12):1905–1912PubMedGoogle Scholar
  40. Dinkla K, Nitsche-Schmitz DP, Barroso V, Reissmann S, Johansson HM, Frick IM, Rohde M, Chhatwal GS (2007) Identification of a streptococcal octapeptide motif involved in acute rheumatic fever. J Biol Chem 282(26):18686–18693PubMedCrossRefGoogle Scholar
  41. Duca E, Teodorovici G, Radu C, Vita A, Talasman-Niculescu P, Bernescu E, Feldi C, Rosca V (1969) A new nephritogenic streptococcus. J Hyg (Lond) 67(4):691–698CrossRefGoogle Scholar
  42. Dudding BA, Ayoub EM (1968) Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med 128(5):1081–1098PubMedCrossRefGoogle Scholar
  43. Eriksson BK, Andersson J, Holm SE, Norgren M (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180(2):410–418PubMedCrossRefGoogle Scholar
  44. Fae KC, da Silva DD, Oshiro SE, Tanaka AC, Pomerantzeff PM, Douay C, Charron D, Toubert A, Cunningham MW, Kalil J, Guilherme L (2006) Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 176(9):5662–5670PubMedGoogle Scholar
  45. Fischetti VA, Pancholi V, Schneewind O (1990) Conservation of a hexapeptide sequence in the anchor region of surface proteins from gram-positive cocci. Mol Microbiol 4(9):1603–1605PubMedCrossRefGoogle Scholar
  46. Fish AJ, Michael AF, Vernier RL, Good RA (1966) Acute serum sickness nephritis in the rabbit. An immune deposit disease. Am J Pathol 49(6):997–1022PubMedGoogle Scholar
  47. Francis AJ, Nimmo GR, Efstratiou A, Galanis V, Nuttall N (1993) Investigation of milk-borne Streptococcus zooepidemicus infection associated with glomerulonephritis in Australia. J Infect 27(3):317–323PubMedCrossRefGoogle Scholar
  48. Futcher PH (1940) Glomerular nephritis following skin infections. Arch Intern Med 65:1192–1210CrossRefGoogle Scholar
  49. Goldstein I, Rebeyrotte P, Parlebas J, Halpern B (1968) Isolation from heart valves of glycopeptides which share immunological properties with Streptococcus haemolyticus group A polysaccharides. Nature 219(5156):866–868PubMedCrossRefGoogle Scholar
  50. Guilherme L, Kalil J (2010) Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 30(1):17–23PubMedCrossRefGoogle Scholar
  51. Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39(1):31–39PubMedCrossRefGoogle Scholar
  52. Haidan A, Talay SR, Rohde M, Sriprakash KS, Currie BJ, Chhatwal GS (2000) Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet 356(9236):1167–1169PubMedCrossRefGoogle Scholar
  53. Hartas J, Sriprakash KS (1999) Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein. Microb Pathog 26(1):25–33PubMedCrossRefGoogle Scholar
  54. Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, Flodgaard H, Lindbom L, Björck L (2004) M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116(3):367–379PubMedCrossRefGoogle Scholar
  55. Humair L, Potter EV, Kwaan HC (1969) The role of fibrinogen in renal disease. I. Production of experimental lesions in mice. J Lab Clin Med 74(1):60–71PubMedGoogle Scholar
  56. Itzek A, Gillen CM, Fulde M, Friedrichs C, Rodloff AC, Chhatwal GS, Nitsche-Schmitz DP (2010) Contribution of plasminogen activation toward the pathogenic potential of oral streptococci. PLoS One 5(11):e13826PubMedCrossRefGoogle Scholar
  57. Jones MN, Holt RG (2004) Activation of plasminogen by Streptococcus mutans. Biochem Biophys Res Commun 322(1):37–41PubMedCrossRefGoogle Scholar
  58. Kantor FS (1965) Fibrogen precipitation by streptococcal M protein. Ii. Renal lesions induced by intravenous injection of M protein into mice and rats. J Exp Med 121:861–872PubMedCrossRefGoogle Scholar
  59. Kaplan MH (1958) Localization of streptococcal antigens in tissues. I. Histologic distribution and persistence of M protein, types 1, 5, 12, and 19 in the tissues of the mouse. J Exp Med 107(3):341–352PubMedCrossRefGoogle Scholar
  60. Kaplan MH, Suchy ML (1964) Immunologic relation of streptococcal and tissue antigens. Ii. Cross-reaction of antisera to mammalian heart tissue with a cell wall constituent of certain strains of group a streptococci. J Exp Med 119:643–650PubMedCrossRefGoogle Scholar
  61. Kaplan MH, Bolande R, Rakita L, Blair J (1964) Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. Association with cardiac failure. N Engl J Med 271:637–645PubMedCrossRefGoogle Scholar
  62. Keitzer R (2005) Acute rheumatic fever (ARF) and poststreptococcal reactive arthritis (PSRA)–an update. Z Rheumatol 64(5):295–307PubMedCrossRefGoogle Scholar
  63. Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8(3):411–426PubMedGoogle Scholar
  64. Lyttle JD, Seegal D, Loeb EN, Jost EL (1938) The serum antistreptolysin titer in acute glomerulonephritis. J Clin Invest 17(5):631–639PubMedCrossRefGoogle Scholar
  65. Massell BF, Honikman LH, Amezcua J (1969) Rheumatic fever following streptococcal vaccination. Report of three cases. Jama 207(6):1115–1119PubMedCrossRefGoogle Scholar
  66. McCarty M (1956) Nature of rheumatic fever. Circulation 14(6):1138–1143PubMedCrossRefGoogle Scholar
  67. McCormack JM, Crossley CA, Ayoub EM, Harley JB, Cunningham MW (1993) Poststreptococcal anti-myosin antibody idiotype associated with systemic lupus erythematosus and Sjogren’s syndrome. J Infect Dis 168(4):915–921PubMedCrossRefGoogle Scholar
  68. McDonald M, Currie BJ, Carapetis JR (2004) Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 4(4):240–245PubMedCrossRefGoogle Scholar
  69. McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR (2006) Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 43(6):683–689PubMedCrossRefGoogle Scholar
  70. Michael AF Jr, Drummond KN, Good RA, Vernier RL (1966) Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest 45(2):237–248PubMedCrossRefGoogle Scholar
  71. Nitsche DP, Johansson HM, Frick IM, Mörgelin M (2006) Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. J Biol Chem 281(3):1670–1679PubMedCrossRefGoogle Scholar
  72. Oda T, Yamakami K, Omasu F, Suzuki S, Miura S, Sugisaki T, Yoshizawa N (2005) Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol 16(1):247–254PubMedCrossRefGoogle Scholar
  73. Ogunbi O, Fadahunsi HO, Ahmed I, Animashaun A, Daniel SO, Onuoha DU, Ogunbi LQ (1978) An epidemiological study of rheumatic fever and rheumatic heart disease in Lagos. J Epidemiol Community Health 32(1):68–71PubMedCrossRefGoogle Scholar
  74. Ohkuni H, Friedman J, van de Rijn I, Fischetti VA, Poon-King T, Zabriskie JB (1983) Immunological studies of post-streptococcal sequelae: serological studies with an extracellular protein associated with nephritogenic streptococci. Clin Exp Immunol 54(1):185–193PubMedGoogle Scholar
  75. Pancholi V, Fischetti VA (1993) Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proc Natl Acad Sci U S A 90(17):8154–8158PubMedCrossRefGoogle Scholar
  76. Parra G, Rodriguez-Iturbe B, Batsford S, Vogt A, Mezzano S, Olavarria F, Exeni R, Laso M, Orta N (1998) Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int 54(2):509–517PubMedCrossRefGoogle Scholar
  77. Phillips GN Jr, Flicker PF, Cohen C, Manjula BN, Fischetti VA (1981) Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A 78(8):4689–4693PubMedCrossRefGoogle Scholar
  78. Proft T, Fraser JD (2003) Bacterial superantigens. Clin Exp Immunol 133(3):299–306PubMedCrossRefGoogle Scholar
  79. Reißmann S, Friedrichs C, Rajkumari R, Itzek A, Fulde M, Rodloff AC, Brahmadathan KN, Chhatwal GS, Nitsche-Schmitz DP (2010) Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India. Emerg Infect Dis 16(4):656–663PubMedCrossRefGoogle Scholar
  80. Reißmann S, Gillen CM, Fulde M, Bergmann R, Nerlich A, Rajkumari R, Brahmadathan KN, Chhatwal GS, Nitsche-Schmitz DP (2012) Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates. PLoS One 7(1):e30122PubMedCrossRefGoogle Scholar
  81. Roberts GJ, Holzel HS, Sury MR, Simmons NA, Gardner P, Longhurst P (1997) Dental bacteremia in children. Pediatr Cardiol 18(1):24–27PubMedCrossRefGoogle Scholar
  82. Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW (2001) Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 183(3):507–511Google Scholar
  83. Rodriguez-Iturbe B, Batsford S (2007) Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 71(11):1094–1104PubMedCrossRefGoogle Scholar
  84. Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC, Hafner D, Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188(10):1578–1586PubMedCrossRefGoogle Scholar
  85. Seegal BC, Andres GA, Hsu KC, Zabriskie JB (1965) Studies on the pathogenesis of acute and progressive glomerulonephritis in man by immunofluorescein and immunoferritin techniques. Fed Proc 24:100–108PubMedGoogle Scholar
  86. Skattum L, Åkesson P, Truedsson L, Sjöholm AG (2006) Antibodies against four proteins from a Streptococcus pyogenes serotype M1 strain and levels of circulating mannan-binding lectin in acute poststreptococcal glomerulonephritis. Int Arch Allergy Immunol 140(1):9–19PubMedCrossRefGoogle Scholar
  87. Sriprakash KS, Hartas J, White A (2002) Antibodies to streptococcal inhibitor of complement function and M peptides in a post-streptococcal glomerulonephritis endemic region of Australia. J Med Microbiol 51(7):589–594PubMedGoogle Scholar
  88. Sriskandan S, Moyes D, Cohen J (1996) Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Lancet 348(9037):1315–1316PubMedCrossRefGoogle Scholar
  89. Steer AC, Batzloff MR, Mulholland K, Carapetis JR (2009a) Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis 22(6):544–552PubMedCrossRefGoogle Scholar
  90. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009b) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9(10):611–616PubMedCrossRefGoogle Scholar
  91. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321(1):1–7PubMedCrossRefGoogle Scholar
  92. Stollerman GH (1969) Nephritogenic and rheumatogenic group A streptococci. J Infect Dis 120(2):258–263PubMedCrossRefGoogle Scholar
  93. Tontsch D, Pankuweit S, Maisch B (2000) Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol 121(2):270–274PubMedCrossRefGoogle Scholar
  94. Treser G, Semar M, Ty A, Agel I, Franklin MA, Lange K (1970) Partial characterization of antigenic streptococcal plasma membrane components in acute glomerulonephritis. J Clin Invest 49(4):762–768PubMedCrossRefGoogle Scholar
  95. Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, Kaplan EL, Musser JM, Hill HR (2004) Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113(3 Pt 1):168–172CrossRefGoogle Scholar
  96. Villarreal H Jr, Fischetti VA, van de Rijn I, Zabriskie JB (1979) The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med 149(2):459–472PubMedCrossRefGoogle Scholar
  97. Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC, Novak R, Verhoef J, Schmitz FJ (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41(11):4941–4949PubMedCrossRefGoogle Scholar
  98. Vogt A, Batsford S, Rodriguez-Iturbe B, Garcia R (1983) Cationic antigens in poststreptococcal glomerulonephritis. Clin Nephrol 20(6):271–279PubMedGoogle Scholar
  99. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ (2000) B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176:154–170PubMedCrossRefGoogle Scholar
  100. Wannamaker LW (1973) The chain that links the heart to the throat. Circulation 48(1):9–18PubMedCrossRefGoogle Scholar
  101. Westling K, Ljungman P, Thalme A, Julander I (2002) Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital. Scand J Infect Dis 34(4):316–319PubMedCrossRefGoogle Scholar
  102. Woolcock JB (1974) The capsule of Streptococcus equi. J Gen Microbiol 85(2):372–375PubMedGoogle Scholar
  103. Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, Boyle MD (2004) Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol 15(7):1785–1793PubMedCrossRefGoogle Scholar
  104. Yu CE, Ferretti JJ (1989) Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun 57(12):3715–3719PubMedGoogle Scholar
  105. Zabriskie JB (1967) Mimetic relationships between group A streptococci and mammalian tissues. Adv Immunol 7:147–188PubMedCrossRefGoogle Scholar
  106. Zabriskie JB, Freimer EH (1966) An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med 124(4):661–678PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • D. Patric Nitsche-Schmitz
    • 2
    Email author
  • Gursharan S. Chhatwal
    • 1
  1. 1.Department of Medical MicrobiologyHelmholtz Centre for Infection ResearchBraunschweigGermany
  2. 2.Helmholtz Centre for Infection ResearchBraunschweigGermany

Personalised recommendations